Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuropharmacoeconomics].

Hou-Chang Chiu1

  • 1Department of Neurology, Shin Kong WHS Memorial Hospital, Taipei, Taiwan. M001012@ms.skh.org.tw

Acta Neurologica Taiwanica
|October 14, 2004
PubMed
Summary
This summary is machine-generated.

Pharmacoeconomics optimizes drug resource allocation using economic evaluations like cost minimization, cost-effectiveness, cost utility, and cost-benefit analysis. This study applies these methods to common neurological drugs for efficient healthcare.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Brain : a journal of neurology·2026
Same author

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Acta neurologica Taiwanica·2026
Same author

Exploring the impact of age of onset on stereoacuity in patients with myasthenia gravis.

Frontiers in ophthalmology·2026
Same author

Clinical Features and Outcome in Myasthenia Gravis Patients with Antimuscle-specific Tyrosine Kinase Antibody: A Retrospective Study.

Acta neurologica Taiwanica·2025
Same author

Machine Learning in Myasthenia Gravis: A Systematic Review of Prognostic Models and AI-Assisted Clinical Assessments.

Diagnostics (Basel, Switzerland)·2025
Same author

Assessment of functioning using the WHODAS 2.0 among people with myasthenia gravis-associated disability: a nationwide follow-up study.

BMC public health·2025

Area of Science:

  • Pharmacoeconomics and Health Economics
  • Quantitative Health Research Methods

Context:

  • Efficient allocation of drug resources is crucial for healthcare systems.
  • Economic evaluation provides formal quantitative methods to assess interventions.
  • Understanding different economic evaluation types is key to pharmacoeconomic analysis.

Purpose:

  • To explain the principles of pharmacoeconomics and economic evaluation.
  • To detail four primary types of economic evaluations: cost minimization, cost-effectiveness, cost utility, and cost-benefit analysis.
  • To apply pharmacoeconomic principles to analyze common neurological drugs.

Summary:

  • Pharmacoeconomics guides efficient drug resource allocation.
  • Four economic evaluation types (CMA, CEA, CUA, CBA) assess intervention costs and outcomes.

Related Experiment Videos

  • Cost utility analysis uses metrics like Quality-Adjusted Life Years (QALY) and Disability-Adjusted Life Years (DALY).
  • This article examines neurological drugs through a pharmacoeconomic lens.

    • Impact:

    • Provides a framework for rational drug selection and resource allocation in neurology.
    • Enhances understanding of economic evaluation methods for healthcare decision-making.
    • Supports evidence-based practice by integrating economic considerations into clinical drug use.